Optimized lentiviral vector production and purification procedure prevents immune response after transduction of mouse brain.
- Published in:
- Gene Therapy, 2003, v. 10, n. 23, p. 1933, doi. 10.1038/sj.gt.3302094
- By:
- Publication type:
- Article
Works matching IS 09697128 AND DT 2003 AND VI 10 AND IP 23
Results: 8
1
2
Human adenovirus type 35: nucleotide sequence and vector development.
- Published in:
- Gene Therapy, 2003, v. 10, n. 23, p. 1941, doi. 10.1038/sj.gt.3302097
- By:
- Publication type:
- Article
3
Adenovirus-mediated transfer of the PTEN gene inhibits human colorectal cancer growth in vitro and in vivo.
- Published in:
- Gene Therapy, 2003, v. 10, n. 23, p. 1961, doi. 10.1038/sj.gt.3302100
- By:
- Publication type:
- Article
4
Ocular transfer of retinal glial cells transduced ex vivo with adenovirus expressing viral IL-10 or CTLA4-Ig inhibits experimental autoimmune uveoretinitis.
- Published in:
- Gene Therapy, 2003, v. 10, n. 23, p. 1970, doi. 10.1038/sj.gt.3302101
- By:
- Publication type:
- Article
5
Conditionally replicative adenovirus expressing a targeting adapter molecule exhibits enhanced oncolytic potency on CAR-deficient tumors.
- Published in:
- Gene Therapy, 2003, v. 10, n. 23, p. 1982, doi. 10.1038/sj.gt.3302103
- By:
- Publication type:
- Article
6
Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) abrogates disease activity in murine collagen-induced arthritis.
- Published in:
- Gene Therapy, 2003, v. 10, n. 23, p. 1950, doi. 10.1038/sj.gt.3302104
- By:
- Publication type:
- Article
7
Downregulation of TNF-a and VEGF expression by Sp1 decoy oligodeoxynucleotides in mouse melanoma tumor.
- Published in:
- Gene Therapy, 2003, v. 10, n. 23, p. 1992, doi. 10.1038/sj.gt.3302111
- By:
- Publication type:
- Article
8
RNA interference gene therapy: Allelic gene inactivation: pinpointing the problem.
- Published in:
- Gene Therapy, 2003, v. 10, n. 23, p. 1931, doi. 10.1038/sj.gt.3302145
- By:
- Publication type:
- Article